Avery Therapeutics, Inc.
PrivateLast Round
Seed Round
Aug 19, 2026
Total Funding Raised
$5.42M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Avery Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Tucson, Arizona. Its latest recorded funding round was a Grant round in May 2019.
Avery Therapeutics, Inc. is a biotechnology company developing immunomodulatory biologic and tissue-engineered therapeutics designed to treat diseases and injuries of human muscles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avery Therapeutics, Inc. Comparables
Compare Avery Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LizarBio Therapeutics | 83% | |
| Alder Therapeutics | 81% | |
| Heartseed | 76% |
For institutional investors. Book with your work email.
Avery Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 19, 2026 | ||||
| Grant | May 15, 2019 | ||||
| Seed | May 22, 2018 | ||||
| Accelerator | Feb 23, 2018 | ||||
| Grant | Jan 1, 2018 | ||||
Seed | Jun 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avery Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Cox Communications | Grant |
| Arizona Geological Survey | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2026
Raised $8.5M in a Seed Round.
- Jul 5, 2025
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Avery Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avery Therapeutics, Inc.'s valuation, stock price, and market status.
Is Avery Therapeutics, Inc. a public or private company?
Avery Therapeutics, Inc. is a private company.
What is the current stock price of Avery Therapeutics, Inc.?
Avery Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Avery Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avery Therapeutics, Inc. worth (valuation)?
Valuation information for Avery Therapeutics, Inc. is not publicly available.
Can I buy Avery Therapeutics, Inc. stock?
Avery Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avery Therapeutics, Inc.'s last funding round?
Avery Therapeutics, Inc.'s most recent funding round was Seed Round on August 19, 2026.
Who are the main investors in Avery Therapeutics, Inc.?
Key investors in Avery Therapeutics, Inc. include NIH RADx, National Heart, Lung, and Blood Institute, Cox Communications, Arizona Geological Survey, National Institutes of Health (NIH).
Will Avery Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Avery Therapeutics, Inc..
How can I track Avery Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Avery Therapeutics, Inc.'s shares on secondary markets.